• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsCorline Biomedical AB
    Picture of Corline Biomedical AB logo

    CLBIO — Corline Biomedical AB Share News

    SEK14.200.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      SEK371.09m
    • Enterprise Value
      SEK338.10m
    • Revenue
      SEK7.65m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • CLBIO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    CLBIO Dividends
    • Brief: Corline Biomedical proposes rights issue of SEK 25.5 million

      19/02/2016 07:04
    • Brief: Corline Biomedical Q3 pre-tax loss widens to SEK 1.1 million

      25/11/2015 08:05
    • Brief: Corline Biomedical: pre-clinical study regarding Renaparin shows very high tolerability

      10/11/2015 10:46
    • Brief: Corline Biomedical applies for Orphan Drug status for Renaparin at FDA

      03/11/2015 09:38
    • Brief: Corline Biomedical is applying for assessing Cytoparin as drug in upcoming clinical study

      01/10/2015 09:48
    • Brief: Corline Biomedical says Corline Pharma connected to AstraZeneca BioVentureHub

      18/06/2015 14:45
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.